Eva Riveira Muñoz

AIDS Research Institute Irsicaixa

Spain

Research Interests

Explore related searches

Professors in Spain Professors in Immunology Immunology professors in Spain

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (21)

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Collaborators (12)

alfonso valencia

Research Professor

Instituciò Catalana de Recerca i Estudis Avancats

SPAIN

View details

Ignacio Blanco

Universitat Autònoma de Barcelona (UAB)

SPAIN

View details

Dominga Rogolino

University of Parma

ITALY

View details

Mireia Margeli Vila

Universitat Autònoma de Barcelona (UAB)

SPAIN

View details

Julià Blanco

Associate Professor

Universitat de Vic - Universitat Central de Catalunya

SPAIN

View details

Javier Martinez-Picado

Associate professor

SPAIN

View details

Julia G Prado

Principal Investigator , head of Virievac team

AIDS Research Institute Irsicaixa

SPAIN

View details

Leire de Campos Mata

Karolinska Institutet

SWEDEN

View details

Carlo Carolis

Head

SPAIN

View details

Ignacio Martinez-Zalacain

Institut Mondor de recherche biomédicale

SPAIN

View details

Christian Brander

ICREA Senior Research Professor

IrsiCaixa

SPAIN

View details

Maria C. Puertas

AIDS Research Institute Irsicaixa

SPAIN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Eva Riveira Muñoz

Research Interests

Explore related searches

Contact this professor

Articles (21)

A human-ACE2 knock-in mouse model for SARS-CoV-2 infection recapitulates respiratory disorders but avoids neurological disease associated with the transgenic K18-hACE2 model.

Quality by Design-Guided Development of Hydrogel-Forming Microneedles for Transdermal Delivery of Enfuvirtide.

Targeting eEF1A reprograms translation and uncovers broad-spectrum antivirals against cap or m<sup>6</sup>A protein synthesis routes.

A monoclonal antibody targeting a large surface of the receptor binding motif shows pan-neutralizing SARS-CoV-2 activity

Immunisation efficacy of a stabilised SARS-CoV-2 spike glycoprotein in two geriatric animal models

SAMHD1 expression is a surrogate marker of immune infiltration and determines prognosis after neoadjuvant chemotherapy in early breast cancer

Immunization with V987H-stabilized Spike glycoprotein protects K18-hACE2 mice and golden Syrian hamsters upon SARS-CoV-2 infection

Nucleotide-Binding Oligomerization Domain 1 (NOD1) Agonists Prevent SARS-CoV-2 Infection in Human Lung Epithelial Cells through Harnessing the Innate Immune Response.

Sirtuin-2, NAD-Dependent Deacetylase, Is a New Potential Therapeutic Target for HIV-1 Infection and HIV-Related Neurological Dysfunction

SAMHD1 expression modulates innate immune activation and correlates with ovarian cancer prognosis

Comparison of Reverse Transcription (RT)-Quantitative PCR and RT-Droplet Digital PCR for Detection of Genomic and Subgenomic SARS-CoV-2 RNA

Novel Spike-stabilized trimers with improved production protect K18-hACE2 mice and golden Syrian hamsters from the highly pathogenic SARS-CoV-2 Beta variant

Author Correction to: SARS-CoV-2 interaction with Siglec-1 mediates trans-infection by dendritic cells.

IRF7 expression correlates with HIV latency reversal upon specific blockade of immune activation

Heterogeneous Infectivity and Pathogenesis of SARS-CoV-2 Variants Beta, Delta and Omicron in Transgenic K18-hACE2 and Wildtype Mice

A Cluster-Randomized Trial of Hydroxychloroquine for Prevention of Covid-19.

Hydroxychloroquine for Early Treatment of Adults with Mild Covid-19: A Randomized-Controlled Trial.

Erratum to: Pharmacological modulation of SAMHD1 activity by CDK4/6 inhibitors improves anticancer therapy (Cancers, (2020), 12)

New indolylarylsulfone non-nucleoside reverse transcriptase inhibitors show low nanomolar inhibition of single and double HIV-1 mutant strains

Pharmacological modulation of SAMHD1 activity by CDK4/6 inhibitors improves anticancer therapy

Targeting HIV-1 RNase H: N'-(2-Hydroxy-benzylidene)-3,4,5-Trihydroxybenzoylhydrazone as Selective Inhibitor Active against NNRTIs-Resistant Variants

Collaborators (12)

alfonso valencia

Ignacio Blanco

Dominga Rogolino

Mireia Margeli Vila

Julià Blanco

Javier Martinez-Picado

Julia G Prado

Leire de Campos Mata

Carlo Carolis

Ignacio Martinez-Zalacain

Christian Brander

Maria C. Puertas

Make your next move.

Eva Riveira Muñoz

Research Interests

Explore related searches

Contact this professor

Articles (21)

A human-ACE2 knock-in mouse model for SARS-CoV-2 infection recapitulates respiratory disorders but avoids neurological disease associated with the transgenic K18-hACE2 model.

Quality by Design-Guided Development of Hydrogel-Forming Microneedles for Transdermal Delivery of Enfuvirtide.

Targeting eEF1A reprograms translation and uncovers broad-spectrum antivirals against cap or m&lt;sup&gt;6&lt;/sup&gt;A protein synthesis routes.

A monoclonal antibody targeting a large surface of the receptor binding motif shows pan-neutralizing SARS-CoV-2 activity

Immunisation efficacy of a stabilised SARS-CoV-2 spike glycoprotein in two geriatric animal models

SAMHD1 expression is a surrogate marker of immune infiltration and determines prognosis after neoadjuvant chemotherapy in early breast cancer

Immunization with V987H-stabilized Spike glycoprotein protects K18-hACE2 mice and golden Syrian hamsters upon SARS-CoV-2 infection

Nucleotide-Binding Oligomerization Domain 1 (NOD1) Agonists Prevent SARS-CoV-2 Infection in Human Lung Epithelial Cells through Harnessing the Innate Immune Response.

Sirtuin-2, NAD-Dependent Deacetylase, Is a New Potential Therapeutic Target for HIV-1 Infection and HIV-Related Neurological Dysfunction

SAMHD1 expression modulates innate immune activation and correlates with ovarian cancer prognosis

Comparison of Reverse Transcription (RT)-Quantitative PCR and RT-Droplet Digital PCR for Detection of Genomic and Subgenomic SARS-CoV-2 RNA

Novel Spike-stabilized trimers with improved production protect K18-hACE2 mice and golden Syrian hamsters from the highly pathogenic SARS-CoV-2 Beta variant

Author Correction to: SARS-CoV-2 interaction with Siglec-1 mediates trans-infection by dendritic cells.

IRF7 expression correlates with HIV latency reversal upon specific blockade of immune activation

Heterogeneous Infectivity and Pathogenesis of SARS-CoV-2 Variants Beta, Delta and Omicron in Transgenic K18-hACE2 and Wildtype Mice

A Cluster-Randomized Trial of Hydroxychloroquine for Prevention of Covid-19.

Hydroxychloroquine for Early Treatment of Adults with Mild Covid-19: A Randomized-Controlled Trial.

Erratum to: Pharmacological modulation of SAMHD1 activity by CDK4/6 inhibitors improves anticancer therapy (Cancers, (2020), 12)

New indolylarylsulfone non-nucleoside reverse transcriptase inhibitors show low nanomolar inhibition of single and double HIV-1 mutant strains

Pharmacological modulation of SAMHD1 activity by CDK4/6 inhibitors improves anticancer therapy

Targeting HIV-1 RNase H: N'-(2-Hydroxy-benzylidene)-3,4,5-Trihydroxybenzoylhydrazone as Selective Inhibitor Active against NNRTIs-Resistant Variants

Collaborators (12)

alfonso valencia

Ignacio Blanco

Dominga Rogolino

Mireia Margeli Vila

Julià Blanco

Javier Martinez-Picado

Julia G Prado

Leire de Campos Mata

Carlo Carolis

Ignacio Martinez-Zalacain

Christian Brander

Maria C. Puertas

Make your next move.

Targeting eEF1A reprograms translation and uncovers broad-spectrum antivirals against cap or m<sup>6</sup>A protein synthesis routes.